给药途径对血浆浓度-时间曲线下面积影响的药代动力学基础。 - Suppr

Suppr

超能文献

Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.

作者信息

Gibaldi M, Feldman S

出版信息

J Pharm Sci. 1969 Dec;58(12):1477-80. doi: 10.1002/jps.2600581211.

DOI:10.1002/jps.2600581211

PMID:5353263

Abstract

摘要

相似文献

Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.给药途径对血浆浓度-时间曲线下面积影响的药代动力学基础。

J Pharm Sci. 1969 Dec;58(12):1477-80. doi: 10.1002/jps.2600581211.

The formulation of aspirin.阿司匹林的配方。

Adv Pharm Sci. 1971;3:107-71.

Influence of the route of administration on the area under the plasma concentration-time curve.给药途径对血浆浓度-时间曲线下面积的影响。

J Pharm Sci. 1969 Jan;58(1):71-5. doi: 10.1002/jps.2600580114.

Influence of route of administration on drug availability.给药途径对药物可利用性的影响。

J Pharm Sci. 1972 Jan;61(1):70-4. doi: 10.1002/jps.2600610111.

Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.大鼠经口灌胃和饮食给药后阿司匹林的药代动力学和药效学特征比较。

Chem Biol Interact. 2009 May 15;179(2-3):233-9. doi: 10.1016/j.cbi.2008.10.008. Epub 2008 Oct 17.

Influence of caffeine on aspirin pharmacokinetics.

Eur J Drug Metab Pharmacokinet. 1986 Jan-Mar;11(1):71-6. doi: 10.1007/BF03189777.

Comparative bioavailability of sustained-release and uncoated aspirin tablets.

Am J Hosp Pharm. 1981 Nov;38(11):1754-6.

Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole.乙酰水杨酸与双嘧达莫的药代动力学相互作用。

Br J Clin Pharmacol. 1985 Mar;19(3):379-83. doi: 10.1111/j.1365-2125.1985.tb02657.x.

[Continous in vivo study of blood salicylate in rabbits after ingestion of free and coated aspirin: influence of particle size].

C R Seances Soc Biol Fil. 1971;165(6):1310-5.

Some factors affecting release and availability of drugs from hard gelatin capsules.

J Pharm Sci. 1970 Oct;59(10):1430-3. doi: 10.1002/jps.2600591013.

引用本文的文献

A model with separate hepato-portal compartment ("first-pass" model): fitting to plasma concentration-time profiles in humans.

Pharm Res. 1997 Feb;14(2):230-7. doi: 10.1023/a:1012065130597.

Clearance concepts in pharmacokinetics.药代动力学中的清除概念。

J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.

The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.（14C）-依酚氯铵在正常Wistar大鼠和肾蒂结扎的纯合子Gunn大鼠中的药代动力学。

Br J Pharmacol. 1974 May;51(1):61-5. doi: 10.1111/j.1476-5381.1974.tb09632.x.

Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine.麦角生物碱：肝脏分布及通过测量胆汁和尿液中的总放射性来评估吸收情况

J Pharmacokinet Biopharm. 1976 Feb;4(1):57-66. doi: 10.1007/BF01271444.

On the pharmacokinetics of phenacetin in man.关于非那西丁在人体中的药代动力学。

Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):261-5. doi: 10.1007/BF00567125.

General pharmacokinetic equations for linear mammillary models with drug absorption into peripheral compartments.具有药物吸收进入外周室的线性乳头状模型的一般药代动力学方程。

Eur J Clin Pharmacol. 1975 Feb 28;8(2):141-8. doi: 10.1007/BF00561564.

Derivation of general equations for linear mammillary models when the drug is administered by different routes.

J Pharmacokinet Biopharm. 1975 Jun;3(3):203-18. doi: 10.1007/BF01067909.

Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

J Pharmacokinet Biopharm. 1975 Jun;3(3):193-201. doi: 10.1007/BF01067908.

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.抗心律失常药双异丙吡胺在健康人体内的药代动力学。

J Pharmacokinet Biopharm. 1976 Jun;4(3):199-230. doi: 10.1007/BF01063614.

Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.“首过”效应和肝外药物消除通用方程的模型无关推导。

Eur J Clin Pharmacol. 1977;11(1):57-64. doi: 10.1007/BF00561789.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验